Biogen Inc. buy Needham & Company LLC
Start price
08.08.23
/
50%
€247.60
Target price
08.08.24
€278.65
Performance (%)
-24.86%
End price
09.08.24
€186.05
Summary
This prediction ended on 09.08.24 with a price of €186.05. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.86%. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -2.015% | -2.015% | 4.219% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Needham & Company LLC from $323.00 to $305.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten